Pardes Biosciences, Inc.

PRDSNASDAQHealthcare

$2.18

+$0.02(+0.93%)

Market Cap$135185724

P/E Ratio—

52W High$3.67

52W Low$0.75

Avg Volume597K

Open$2.16

Beta0.42

Insider Trades Ownership Employees

Pardes Biosciences, Inc. (PRDS) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PRDS · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

∞

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Pardes Biosciences, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

PRDS insider buying and selling by quarter

PRDS insider selling · PRDS insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

29.4M14.7M0

2021 Q4

2022 Q1

2022 Q2

2022 Q3

2022 Q4

2023 Q1

2023 Q2

2023 Q3

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

PRDS executive sell shares · PRDS board member insider trading · PRDS insider trading SEC filing

Showing 17 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Aug 31, 2023	Tananbaum James B. President and CEO · Director	Other	1,000	$0.00	$0	1,000	Form 4
Aug 31, 2023	Tananbaum James B. President and CEO · Director	Other	16,813,146	$0.00	$2K	0	Form 4
Aug 31, 2023	WIGGANS THOMAS G CEO · Director	Other	50,000	$2.13	$107K	0	Form 4
Aug 31, 2023	Varney Michael David Director	Other	70,390	$2.13	$150K	0	Form 4
Aug 31, 2023	Lopatin Uri A Director	Other	351,948	$2.13	$750K	0	Form 4
Aug 31, 2023	LOBELL J JAY Director	Other	1,163,861	$2.13	$2.48M⚡	0	Form 4
Aug 31, 2023	Lacy Elizabeth H. General Counsel, Secretary	Other	211,169	$2.13	$450K	0	Form 4
Aug 31, 2023	HENSON HEIDI CFO	Other	316,753	$2.13	$675K	0	Form 4
Aug 31, 2023	AUERBACH MARK Director	Other	70,390	$2.13	$150K	0	Form 4
Apr 5, 2023	Foresite Capital Opportunity Management V, LLC 10 percent owner	Purchase	773,952	$1.50	$1.16M⚡	8,773,134	Form 4
Apr 5, 2023	Foresite Capital Management V, LLC 10 percent owner	Purchase	773,952	$1.50	$1.16M⚡	13,583,762	Form 4
Dec 8, 2022	Brusky Sean P. Chief Commercial Officer	Purchase	21,000	$1.19	$25K	21,000	Form 4
Dec 5, 2022	WIGGANS THOMAS G CEO	Purchase	12,500	$1.09	$14K	50,000	Form 4
Dec 1, 2022	Foresite Capital Management V, LLC Director	Purchase	637,420	$0.85	$542K	12,809,810	Form 4
Dec 2, 2022	WIGGANS THOMAS G CEO	Purchase	12,500	$1.07	$13K	37,500	Form 4
Dec 1, 2022	WIGGANS THOMAS G CEO	Purchase	25,000	$1.04	$26K	25,000	Form 4
Jul 19, 2022	LOBELL J JAY Director	Other	1,163,861	—	—	1,163,861	Form 4

Tananbaum James B.

President and CEO · Director

Other

Date

Aug 31

1,000

Price

$0.00

Value

View Form 4 on SEC.gov

Tananbaum James B.

President and CEO · Director

Other

Date

Aug 31

16,813,146

Price

$0.00

Value

$2K

View Form 4 on SEC.gov

WIGGANS THOMAS G

CEO · Director

Other

Date

Aug 31

50,000

Price

$2.13

Value

$107K

View Form 4 on SEC.gov

Varney Michael David

Director

Other

Date

Aug 31

70,390

Price

$2.13

Value

$150K

View Form 4 on SEC.gov

Lopatin Uri A

Director

Other

Date

Aug 31

351,948

Price

$2.13

Value

$750K

View Form 4 on SEC.gov

LOBELL J JAY

Director

Other

Date

Aug 31

1,163,861

Price

$2.13

Value

$2.48M ⚡

View Form 4 on SEC.gov

Lacy Elizabeth H.

General Counsel, Secretary

Other

Date

Aug 31

211,169

Price

$2.13

Value

$450K

View Form 4 on SEC.gov

HENSON HEIDI

CFO

Other

Date

Aug 31

316,753

Price

$2.13

Value

$675K

View Form 4 on SEC.gov

AUERBACH MARK

Director

Other

Date

Aug 31

70,390

Price

$2.13

Value

$150K

View Form 4 on SEC.gov

Foresite Capital Opportunity Management V, LLC

10 percent owner

Purchase

Date

Apr 5

773,952

Price

$1.50

Value

$1.16M ⚡

View Form 4 on SEC.gov

Foresite Capital Management V, LLC

10 percent owner

Purchase

Date

Apr 5

773,952

Price

$1.50

Value

$1.16M ⚡

View Form 4 on SEC.gov

Brusky Sean P.

Chief Commercial Officer

Purchase

Date

Dec 8

21,000

Price

$1.19

Value

$25K

View Form 4 on SEC.gov

WIGGANS THOMAS G

CEO

Purchase

Date

Dec 5

12,500

Price

$1.09

Value

$14K

View Form 4 on SEC.gov

Foresite Capital Management V, LLC

Director

Purchase

Date

Dec 1

637,420

Price

$0.85

Value

$542K

View Form 4 on SEC.gov

WIGGANS THOMAS G

CEO

Purchase

Date

Dec 2

12,500

Price

$1.07

Value

$13K

View Form 4 on SEC.gov

WIGGANS THOMAS G

CEO

Purchase

Date

Dec 1

25,000

Price

$1.04

Value

$26K

View Form 4 on SEC.gov

LOBELL J JAY

Director

Other

Date

Jul 19

1,163,861

Price

—

Value

—

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PRDS insider trading

PRDS insider trades

Pardes Biosciences, Inc. (PRDS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including PRDS. Over the past 12 months, 0 insiders have filed transactions with the SEC. PRDS insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Pardes Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

PRDS insider trading · 5 questions

The insiders of Pardes Biosciences, Inc. (PRDS) include executives and directors such as PRDS, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PRDS board member insider tradingwho are PRDS insidersPRDS insider rosterPardes Biosciences, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026